Implications of Auditory Neuropathy for EHDI Programs. Vickie Thomson MA Sandra Gabbard, PhD Arlene Stredler Brown, MA Marion Downs Hearing Center Denver, CO. Faculty Disclosure Information. In the past 12 months, I have not had a significant financial interest
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Vickie Thomson MA
Sandra Gabbard, PhD
Arlene Stredler Brown, MA
Marion Downs Hearing Center
In the past 12 months, I have not had a significant financial interest
or other relationship with the manufacturer(s) of the product(s) or
provider(s) of the service(s) that will be discussed in my presentation.
This presentation will (not) include discussion of pharmaceuticals or
devices that have not been approved by the FDA or if you will be
discussing unapproved or "off-label" uses of pharmaceuticals or devices.
39% > 38 weeks gestation
Aoyagi et al, 1994, Levi et al, 1995, Rance et al, 1995, Lins et al, 1996, Picton et al, 1998
Arlene Stredler Brown, CCC-SLP, CED
It is to be hoped that, in the future, intervention
and education for children with auditory neuropathy will be more prescriptive.
At this time, however, professionals have the responsibility to work as a team, to identify the developmental profile of each child in an effort to identify appropriate intervention strategies. And, as professionals, we have a responsibility to remain committed to the method or methodology that works for each child.